Case report: molecular features and treatment options for small bowel adenocarcinoma
Access noteAcceso abierto
MetadataShow full item record
Small bowel adenocarcinoma (SBA) is a rare malignancy characterized by poor prognosis. Recent efforts have sought to elucidate the genetic landscape and the molecular drivers behind this disease. Herein, we report the main molecular alterations in two metastatic (stage IV) SBA patients. Interestingly, one of them had gene alterations that affected signaling pathways previously described for SBA. However, a second patient displayed previously unreported alterations in this particular tumor type. Based on these findings we discuss potential treatment options for patients affected by this rare, aggressive disease.
Artículo de publícación WoS
Quote ItemFrontiers in Oncology March 2021 Volume 11 Article 593561
The following license files are associated with this item: